drugset / Trial / NCT02482324
Phase 1 Study of ALZT-OP1 Combination Therapy in Normal Healthy Volunteers
Phase 1
Completed
26 enrolled
AZTherapies, Inc.
KCAS · collabPanax Clinical Research · collabPharma Consulting Group AB · collab
RandomizedCrossoverOpen-label
Summary
This is an open-labeled, cross-over design, pharmacokinetic study, to determine the pharmacokinetics of ALZT-OP1 (a combination drug therapy) designated as ALZT-OP1a and ALZT-OP1b, in both plasma and CSF, following co-administration of the active compounds, in healthy volunteers, aged 55-75, and in good general health.
Timeline
- Start
- 2015-06
- Primary completion
- 2015-07
- Completion
- 2015-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ALZT-OP1a | Unknown | — | Inhaled |
| Subject | Ibuprofen | Small molecule | — | Oral |
Indications
No indication recorded.